Last updated 2026-07-20
- Acquired by Microbot Medical for $370k, May 2018
- Raised Series A led by Medvest, Jun 2014
- Raised Seed round led by Maayan Ventures, May 2012
Total raised
—
Last: Undisclosed Round 2014-07
Stage
Acquired
Founded
2012
Headcount
6
HQ
Nesher, Israel
Sector
Health Tech & Life Sciences
About
CardioSert developed a tool to support interventional cardiologists in crossing complex lesions, known as chronic total occlusion (CTO), during percutaneous coronary intervention (PCI) procedures. The CardioSert tool enables physicians to gently maneuver within micro-channels that pass through artery blockages. The device is also equipped with a unique means for sensing the level of artery recanalization or assessing artery blockages pre-operation through measurement of the Frictional Flow Ratio (FFR).
Funding history · 2 rounds · — total
2014-06
A Round
Undisclosed
★ Medvest★ Magna Capital Partners
2012-05
Seed
Undisclosed
★ Maayan Ventures
Q&A
- What is CardioSert's primary business?
- CardioSert develops advanced tools for interventional cardiologists performing PCI procedures, including a proprietary guide wire for crossing complex lesions and a pressure guide wire for measuring fractional flow reserve (FFR).
- When was CardioSert founded?
- CardioSert was founded in March 2012.
- What is the current status of CardioSert?
- CardioSert was acquired by Microbot Medical in May 2018.
- Who were the lead investors in CardioSert's June 2012 funding round?
- Maayan Ventures was the lead investor in CardioSert's June 2012 funding round.
- Which investors participated in CardioSert's July 2014 funding round?
- Magna Capital Partners and Medvest participated in CardioSert's July 2014 funding round.
- How many employees does CardioSert have?
- CardioSert has 1-10 employees.
- Who are the co-founders of CardioSert?
- The co-founders of CardioSert are Avrahan Shkalim, who serves as CEO, and Noam Peleg, who serves as CTO.
- What happened to CardioSert's technology after the acquisition?
- In May 2019, Microbot Medical acquired a novel patent-protected technology from CardioSert, and now owns CardioSert's innovative technology, including R&D information, technical know-how, and intellectual property.
Team · 2
Avraham Shekalim
Founder · Founder & Chairman
Noam Peleg
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Sensing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
medical-devicesmedical-technologiescardiologysurgerysurgery-tools
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cardiosert.com/ |
|---|
Identifiers & details
| Founded | 2012 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Acquired by Microbot Medical on May, 2018 |
Acquisitions & public offerings
Acquired by Microbot Medical 2018-05 $370K
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | cardiosert.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514755776 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2012-03-29 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 2 — dissolution (2) |
| Registered address | השושנים 24 נשר |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-26 | התנגדות לפירוק מרצון מזורז |
| 2026-01-25 | פירוק מרצון מזורז |